Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates

Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised

Eli Lilly (LLY) Q1 Earnings Top, Sales Miss, 2024 View Raised

Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates

BioMarin (BMRN) Beats on Q1 Earnings, Voxzogo Drives Sales

Corcept (CORT) Posts Positive Data From Cushing's Syndrome Study

Sanofi (SNY) Rilzabrutinib Shows Benefit in Blood Disorder Study

Ligand to Report First Quarter 2024 Financial Results on May 7, 2024

Will Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition?

Roche (RHHBY) Alecensa Wins FDA Nod for Label Expansion

Vanda (VNDA) Rejects Takeover Interest From Future Pak, Stock Up

Wall Street Analysts Predict a 45.56% Upside in Ligand (LGND): Here's What You Should Know

Wall Street Analysts Predict a 45.56% Upside in Ligand (LGND): Here's What You Should Know

Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why

Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study

Corcept (CORT) Completes Enrollment in Phase II ALS Study

Neumora (NMRA) Down on FDA Clinical Hold on Neurology Drug

Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why

Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors

AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids